Genetics
CleanNA launches CE-IVD product for quick and reliable viral DNA and RNA extraction
06/03/2024 — WADDINXVEEN, Netherlands — (BUSINESS WIRE) CleanNA, a Dutch manufacturer of magnetic bead-based nucleic acid extraction kits and systems, launched its second CE-IVD marked product. The company’s Clean Quick […]
Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology
24/01/2024 — SAN CARLOS, Calif. — (BUSINESS WIRE) Elegen, a leader in DNA manufacturing innovation, today announced a collaboration and licensing agreement with GSK (LSE/NYSE: GSK) to enable its use […]
CleanNA Enters the Molecular Diagnostics Market by Launching Its First CE-IVD Product
06/11/2023 — WADDINXVEEN, Netherlands — (BUSINESS WIRE) CleanNA, a Dutch manufacturer of magnetic bead-based nucleic acid extraction kits, launched its first CE-IVD marked product. Their ‘Clean Cell Free DNA Kit’ […]
Mary Kay Inc. & European Society for Dermatological Research Partner to Award Educational Research Grants Advancing Skin Health/Skin Disease
17/05/2023 — DALLAS — (BUSINESS WIRE) Mary Kay Inc., a global leader in skin care innovation, in partnership with the European Society for Dermatological Research, recently announced its inaugural Mary […]
Medimaps Group Appoints Meinhard F. Schmidt as Board Chairman; Adds Anne Le Grand and Five Additional Board Members
28/11/2022 — GENEVA — (BUSINESS WIRE) Medimaps Group (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced new appointments to its Board of […]
Oxular Limited Appoints Industry Veteran James Jogerst as Chief Business Officer
07/11/2022 — OXFORD, England — (BUSINESS WIRE) Oxular Limited, a clinical-stage retinal therapeutics company developing long-lasting targeted treatments for retinal disorders to improve patients’ vision, today announced the appointment of […]
Caravan Biologix, Inc. Collaborates with MDimune on Cell-Derived NanoVesicles for Cancer
15/09/2022 — BRISTOL, N.J. & SEOUL — (BUSINESS WIRE) Caravan Biologix, Inc., a developer of novel cell-derived vesicle (CDV) therapeutics targeting specific cancers and gene therapy-related diseases, today announced that […]
CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society
Over 25 Abstracts Highlight Value of AlloSure and AlloSeq cfDNA 12/09/2022 — BRISBANE, Calif. — (BUSINESS WIRE) CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, […]
Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting
Emendo Biotherapeutics revealed pre-clinical data for the treatment of ELANE-related Severe Congenital Neutropenia using an allele-specific editing approach, generating a highly specific editing composition that achieves both no off-targets and […]
Agendia to Deliver Robust Suite of Data Advancing Breast Cancer Care at ASCO 2022
Company showcases pipeline developments and sub-studies from the revolutionary FLEX Registry with posters focused on patient-centric insights Two oral discussion sessions to focus on RUO ImPrint immune signature and BluePrint® […]
Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma
26/04/2022 — MENLO PARK, Calif. & COPENHAGEN, Denmark — (BUSINESS WIRE) Evaxion Biotech A/S (Nasdaq: EVAX) and Personalis (Nasdaq: PSNL) announced today that Evaxion will deploy Personalis’ ImmunoID NeXT Platform […]
Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene
Tool detects increasingly important biomarker for immunotherapy 12/04/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the […]
Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022
Profiling feasibility study uses a combined transcriptome and exome approach to confirm and augment upon previous molecular subtyping method in colorectal cancer 11/04/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) […]
Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022
23/03/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced it is presenting new data in scientific posters at […]
Agendia Appoints Elizabeth Hanna as Executive Vice President and Chief Commercial Officer, Bolsters Company’s Global Market Growth Strategy
15/03/2022 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, Inc., a commercial stage company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that […]
Personalis Announces Collaboration with UC San Diego Moores Cancer Center for Clinical Genomic Testing and Research into Composite Biomarkers and Minimal Residual Disease Detection
15/02/2022 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced a strategic collaboration with the Moores Cancer Center […]
Humanigen and Cenexi Announce Collaboration to Manufacture Lenzilumab in France
Cenexi to Become Preferred Drug Product Supplier for France and the European Union 09/02/2022 — BURLINGAME, Calif. & FONTENAY-SOUS-BOIS, France — (BUSINESS WIRE) Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage […]
Agendia Study Demonstrates MammaPrint® and BluePrint® Capture Full Spectrum of Early Breast Cancer Biology, Providing Opportunity for Highly Individualized Treatment
New analysis in peer-reviewed journal Genes, Chromosomes and Cancer further establishes that MammaPrint and BluePrint both comprehensively represent and capture the 10 hallmarks of cancer in early-stage breast cancer Study […]
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
Multi-year partnership to advance the use of next-generation sequencing for decentralized oncology testing, to bring improved insights to patients with breast cancer globally 10/01/2022 — IRVINE, Calif. & AMSTERDAM — […]
Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
16/12/2021 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of NeXT Personal, a next-generation, tumor-informed liquid […]
Agendia Spotlight Poster at SABCS 2021 Confirms Utility of BluePrint® as Biomarker Subtyping Test to Guide Neoadjuvant Chemotherapy Decisions
Additional research from the real-world FLEX Registry focuses on age effect and lymph node status for patients with breast cancer 10/12/2021 — IRVINE, Calif. & AMSTERDAM — (BUSINESS WIRE) Agendia, […]
Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
02/11/2021 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the latest expansion of the Personalis NeXT Platform® adding […]
FINVASIA Acquires Gini Health, Expands Into Healthcare Services
28/10/2021 — CHANDIGARH, India — (BUSINESS WIRE) FINVASIA, today, announced its investment in Gini Health, a Canada based healthcare technology company that pioneered DNA and lifestyle data based personalized health […]
Ultivue Announces New Independent Board Members
19/08/2021 — CAMBRIDGE, Mass. — (BUSINESS WIRE) Ultivue announces the addition of two independent board members, Fenel Eloi and Mary Pat Lancelotta, to help strengthen its position as a leader […]
Ultivue Announces Co-Marketing Agreement with Fluidigm for Biomarker Imaging Solutions for Precision Medicine
05/08/2021 — CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif. — (BUSINESS WIRE) Ultivue, Inc. and Fluidigm Corporation (Nasdaq:FLDM) today announced a co-marketing agreement in which the companies will offer customers […]
Adagio Therapeutics Appoints David Hering, Global COVID-19 Vaccine Expert, as Chief Operating Officer
19/07/2021 — WALTHAM, Mass. — (BUSINESS WIRE) Adagio Therapeutics, Inc., a biotechnology company developing highly differentiated antibodies to broadly neutralize coronaviruses, today announced that David Hering has been appointed as […]
Personalis Announces NeXT Level Biomarkers Symposium
22/06/2021 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced its inaugural event, NeXT Level Biomarkers Symposium, which will […]
Personalis, Inc. to Present at Biomarkers Week Online 2021
17/05/2021 — MENLO PARK, Calif. — (BUSINESS WIRE) Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present at Biomarkers Week Online […]
GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit
Exclusive agreement for region brings GenScript’s innovative cPass™ kit to Spain, Portugal and Andorra 14/04/2021 — LEIDEN, Netherlands & BILBAO, Spain — (BUSINESS WIRE) GenScript Biotech (Netherlands) BV, a subsidiary […]
Centessa Pharmaceuticals Launches with $250 Million Series A Financing and Unveils a New Kind of Pharmaceutical R&D Model
Merger of 10 Privately Held Biotech Companies with Highly Validated Programs Led by Industry Leading Teams to Operate Under Centessa Umbrella Company Founded by Medicxi with Financing Led by General […]